Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
642.50
Change Change %
-3.70 -0.57%

Updated:18 Sep, 2018, 15:59 PM IST

BSE
642.30
Change Change %
-3.85 -0.60%

Updated:18 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Religare
N/A
21-03-2014 Buy 585.00 740.00
N/A
Target Hit Long (1Y)
21-03-2015

Religare maintains buy on Sun Pharma

Stock correction is overdone. Expect strong guidance by Sun post Q4. New competitor in Doxil is at least a year away. Valuations reasonable post correction. 

Top